EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD31 regulates metabolic switch in Treg migration attenuates rheumatoid arthritis

Meijun Liu, Wengqiong Huang, Xiaoli Chen, Zongzhen Meng, Jiawen Yang, Loiola Rodrigo Azevedo, Xiaojiao Zheng, Hao Shen, Wei Jia, Aiping Lyu, Kenneth Cp Cheung iD

Clinical and Translational Medicine · 2025-08 · 15 (8)

DOI: 10.1002/ctm2.70441 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 15.08.2025. Verfasst von Meijun Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Phenome Research Center, Hong Kong Baptist University, Hong Kong, China. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Arthritis, Rheumatoid, Cell Movement. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HKBU Cheung On Tak Endowed Professor in Chinese Medicine, the France/Hong Kong Joint Research Scheme, General Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD31 (PECAM‐1) plays a critical role in T cell migration, whilst its immunoreceptor tyrosine inhibitory motifs (ITIMs), Y663 and Y686, are recognised for their roles in endothelial function, the precise mechanism in regulating immune cell remains elusive. Here, we demonstrate that CD31 is essential for Treg migration. Upon ITIM engagement, CD31 activates and interacts with the protein tyrosine phosphatase SHP2. In vivo, CD31 Y663F gene transfer recapitulates the wild‐type migration phenotype, driven by a metabolic switch to fructose utilisation under the regulation of the PFKFB3 gene. Conversely, the Y686F mutation impairs Tregs migration by disrupting both glycolysis and the switch to fructose metabolism, thus promoting the mitochondrial function via activation of the RNF111/OGT pathway. Our findings reveal a novel role for CD31 ITIMs in orchestrating a metabolic that is switch crucial for Treg migration. This understanding of CD31 polymorphisms and their impact on Treg migration offers potential therapeutic avenues for autoimmune diseases, particularly rheumatoid arthritis (RA). Key points CD31 Y663F‐mutant Tregs exhibit a glucose‐to‐fructose metabolic shift, characterised by reduced glucose uptake and enhanced fructose utilisation regulated by PFKFB3. CD31 Y686F mutation disrupts both glycolysis and fructose metabolism in Tregs, shifting energy production towards mitochondrial function via the RNF111/OGT pathway. These findings highlight a novel mechanism by which CD31 ITIMs control Treg migration, offering new therapeutic targets for autoimmune diseases such as RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryArthritis, RheumatoidCell MovementAnimalsMiceHumansPhosphofructokinase-2

Stichwörter der Autor:innen

CD31 ITIMsPFKFB3RNF111/OGT pathwayTregs migrationmetabolic switch

Substanzen

Phosphofructokinase-2

Autor:innen und Institutionen

  • Phenome Research Center, Hong Kong Baptist University, Hong Kong, China.
  • School of Life Science, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
  • Oroxcell, Parc Biocitech, Romainville, France.
  • Center for Translational Medicine and Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Orthopaedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China.

ORCID-Profile: Kenneth Cp Cheung

Förderung

  • HKBU Cheung On Tak Endowed Professor in Chinese Medicine
  • the France/Hong Kong Joint Research Scheme
  • General Research Fund
  • HKBU Start Up Grant for New Academics
  • HKBU Strategic Development Fund

Zitieren

APA

Liu, M., Huang, W., Chen, X., Meng, Z., Yang, J., Azevedo, L. R., Zheng, X., Shen, H., Jia, W., Lyu, A., & Cheung, K. C. (2025). CD31 regulates metabolic switch in Treg migration attenuates rheumatoid arthritis. Clinical and Translational Medicine, 15(8). https://doi.org/10.1002/ctm2.70441

Vancouver

Liu M, Huang W, Chen X, Meng Z, Yang J, Azevedo LR, et al. CD31 regulates metabolic switch in Treg migration attenuates rheumatoid arthritis. Clinical and Translational Medicine. 2025;15(8). doi:10.1002/ctm2.70441

BibTeX
@article{Liu2025,
  author = {Liu, Meijun and Huang, Wengqiong and Chen, Xiaoli and Meng, Zongzhen and Yang, Jiawen and Azevedo, Loiola Rodrigo and Zheng, Xiaojiao and Shen, Hao and Jia, Wei and Lyu, Aiping and Cheung, Kenneth Cp},
  title = {CD31 regulates metabolic switch in Treg migration attenuates rheumatoid arthritis},
  journal = {Clinical and Translational Medicine},
  year = {2025},
  volume = {15},
  number = {8},
  doi = {10.1002/ctm2.70441}
}
Kostenlos starten →